Since our inception in 1990, we’ve strived to work as a ‘trusted partner’ to our clients, collaborating, innovating and finding new ways to improve outcomes.

ICON has worked with and developed strategic partnerships with many of the world’s largest pharma companies. And every partnership into which ICON has entered is still ongoing and evolving with our clients’ needs. We’ve built our reputation on enduring partnerships that advance medicine and make a difference in the world. Our award-winning study execution capabilities have led to the approval of 18 of the world’s top 20 best-selling drugs.

We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Our partnership models seek to integrate our own multidisciplinary expertise and that of our clients, resulting in more efficient trial design, effective utilisation of digital technologies and real world data, and optimal patient recruitment and engagement.